LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--In a landmark move, the FDA recently announced plans to phase out the requirement for animal testing in drug development, encouraging the use of ...
Northwestern University scientists have developed the most advanced organoid model for human spinal cord injury to date. In a new study, the research team used lab-grown human spinal cord ...
One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with ...
Hosted on MSN
Scientists advance efforts to create 'virtual cell lab' as testing ground for future research with live cells
Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body. Led by ...
For the first time, researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time. The ...
Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Without even thinking about it, the bone marrow in your body is ...
Scientists have grown a human embryo-like structure in a lab which replicates very early human development - including the production of blood stem cells. The lab-grown embryo model could help ...
A newly created cell model of the amniotic sac could reveal new insights into early pregnancy, as well as generate helpful products for medical use. When you purchase through links on our site, we may ...
An international team of researchers led by Max Delbrück Center Scientific Director Professor Maike Sander, MD, has for the first time developed an organoid model of human pluripotent stem ...
Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...
Patient-derived glioblastoma organoid treated with dual-target CAR-T cells. T cells (magenta) infiltrate the tumor organoid and kill tumor cells (blue) (yellow indicates dying cells). PHILADELPHIA— ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results